Quality measure attainment in patients with type 2 diabetes mellitus

American Journal of Managed Care

Volumn 20, Issue 1 SUPPL., 2014, Pages

  Lafeuille, Marie Hélène ^d   Grittner, Amanda M ^d   Gravel, Jonathan ^d   Bailey, Robert A ^a   Martin, Silas ^a   Garber, Lawrence ^c   Duh, Mei Sheng ^b   Lefebvre, Patrick ^d  

^a JANSSEN RESEARCH AND DEVELOPMENT   (United States)

^b ANALYSIS GROUP   (United States)

^c Reliant Medical Group Inc   (United States)

^d INSTITUTE FOR RESEARCH IN IMMUNOLOGY AND CANCER   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIHYPERTENSIVE AGENT; HEMOGLOBIN A1C; LOOP DIURETIC AGENT; LOW DENSITY LIPOPROTEIN CHOLESTEROL; METFORMIN; SULFONYLUREA; ANTIDIABETIC AGENT; GLYCOSYLATED HEMOGLOBIN; SULFONYLUREA DERIVATIVE;

ADULT; AGED; ARTICLE; BLOOD PRESSURE; BODY MASS; CARDIOVASCULAR DISEASE; CHOLESTEROL BLOOD LEVEL; COHORT ANALYSIS; COMORBIDITY; DIABETES CONTROL; DIABETIC NEPHROPATHY; DIABETIC NEUROPATHY; DIABETIC PATIENT; DIABETIC RETINOPATHY; ELECTRONIC MEDICAL RECORD; FEMALE; GLYCEMIC CONTROL; GOAL ATTAINMENT; GROUPS BY AGE; HEALTH CARE COST; HEALTH INSURANCE; HEART FAILURE; HUMAN; HYPERLIPIDEMIA; HYPERTENSION; LIFESTYLE MODIFICATION; LONGITUDINAL STUDY; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; OUTCOME ASSESSMENT; PRESCRIPTION; PRIORITY JOURNAL; AGE; BLOOD; CARDIOVASCULAR DISEASES; COMPLICATION; DIABETES MELLITUS, TYPE 2; DRUG COMBINATION; ECONOMICS; HEALTH CARE QUALITY; INCIDENCE; INSURANCE; MIDDLE AGED; RETROSPECTIVE STUDY; SOCIOECONOMICS; STATISTICS AND NUMERICAL DATA; VERY ELDERLY;

AGE FACTORS; AGED; AGED, 80 AND OVER; ANTIHYPERTENSIVE AGENTS; BLOOD PRESSURE; BODY MASS INDEX; CARDIOVASCULAR DISEASES; CHOLESTEROL, LDL; COMORBIDITY; DIABETES MELLITUS, TYPE 2; DRUG THERAPY, COMBINATION; FEMALE; HEALTH EXPENDITURES; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; HYPOGLYCEMIC AGENTS; INCIDENCE; INSURANCE CLAIM REVIEW; MALE; METFORMIN; MIDDLE AGED; QUALITY INDICATORS, HEALTH CARE; RETROSPECTIVE STUDIES; SOCIOECONOMIC FACTORS; SODIUM POTASSIUM CHLORIDE SYMPORTER INHIBITORS; SULFONYLUREA COMPOUNDS;

EID: 84901713727     PISSN: 10880224     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (20)

1. American Diabetes Association. Economic costs of diabetes in the U.S. in 2012. Diabetes Care. 2013;36(4):1033-1046.
2. Cowie CC, Rust KF, Ford ES, et al. Full accounting of diabetes and pre-diabetes in the U.S. population in 1988-1994 and 2005- 2006. Diabetes Care. 2009;32(2):287-294.
3. Chau D, Edelman SV. Clinical management of diabetes in the elderly. Clinical Diabetes. 2001;19(4):172-175.
4. American Diabetes Association. Standards of medical care in diabetes - 2011. Diabetes Care. 2011;34(suppl 1):S11-S61.
5. Centers for Medicare & Medicaid Services. Medicare program; Medicare Shared Savings Program: accountable care organizations: final rule. Fed Regist. 2011;76(212):67802-67990.
6. RTI International, Telligen. Accountable care organization 2012 program analysis, quality performance standards narrative measure specifications, final report. Research Triangle Park, NC: RTI International; December 12, 2011. RTI Project No. 0213195 .000.004.
7. Eddy DM, Shah R. A simulation shows limited savings from meeting quality targets under the Medicare Shared Savings program. Health Aff (Millwood). 2012;31(11):2554- 2562.
8. Obesity and Overweight. World Health Organization website. www.who.int/dietphysicalactivity/media/en/gsfs-obesity.pdf. Accessed October 8, 2013.
9. Cebul RD, Love TE, Jain AK, Hebert CJ. Electronic health records and quality of diabetes care. N Engl J Med. 2011;365(9): 825-833.
10. Zhuo X, Zhang P, Hoerger TJ. Lifetime direct medical costs of treating type 2 diabetes and diabetic complications. Am J Prev Med. 2013;45(3):253-261.
11. Nathan DM, Buse JB, Davidson MB, et al American Diabetes Association; European Association for Study of Diabetes. Medical management of hyperglycemia in type 2 diabetes: a consensus algorithm for the initiation and adjustment of therapy: a consensus statement of the American Diabetes Association and the European Association for the Study of Diabetes. Diabetes Care. 2009;32(1): 193-203.
12. Manning WG, Basu A, Mullahy J. Generalized modeling approaches to risk adjustment of skewed outcomes data. J Health Econ. 2005;24(3):465-488. (Pubitemid 40461909)
13. Davidson R, MacKinnon JG. Econometric Theory and Methods. New York, NY: Oxford University Press; 2004.
14. Manning WG, Basu A, Mullahy J. Generalized modeling approaches to risk adjustment of skewed outcomes data. J Health Econ. 2005;24(3):465-488. (Pubitemid 40461909)
15. Shetty S, Secnik K, Oglesby AK. Relationship of glycemic control to total diabetes-related costs for managed care health plan members with type 2 diabetes. J Manag Care Pharm. 2005;11(7): 559-564.
16. Thompson D, Brown JB, Nichols GA, Elmer PJ, Oster G. Body mass index and future healthcare costs: a retrospective cohort study. Obes Res. 2001;9(3):210-218. (Pubitemid 33600282)
17. Dilla T, Valladares A, Nicolay C, Salvador J, Reviriego J, Costi M. Healthcare costs associated with change in body mass index in patients with type 2 diabetes mellitus in Spain: the ECOBIM study. Appl Health Econ Health Policy. 2012;10(6):417-430.
18. Shi L, Ye X, Lu M, et al. Clinical and economic benefits associated with the achievement of both HbA1c and LDL cholesterol goals in veterans with type 2 diabetes mellitus. Diabetes Care. 2013;36(10):3297-3304.
19. Kalda R, Rätsep A, Lember M. Predictors of quality of life of patients with type 2 diabetes. Patient Prefer Adherence. 2008; 2:21-26.
20. Gaede P, Vedel P, Larsen N, Jensen GV, Parving HH, Pedersen O. Multifactorial intervention and cardiovascular disease in patients with type 2 diabetes. N Engl J Med. 2003;348(5): 383-393. (Pubitemid 36159355)